Yao Wenqing, EVP, Discovery Medicinal and P at INCYTE CORP (INCY), sold 20,031 shares at $90.29 ($1.8M) on 2015-04-07, disclosed to the SEC on 2015-04-08.
Scheduled sale ($1.8M) by EVP, Discovery Medicinal and P under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $89.75 | 5,000 | $449K | 24.9% |
| 2 | $90.22 | 3,178 | $287K | 15.9% |
| 3 | $90.25 | 5,000 | $451K | 25.0% |
| 4 | $90.27 | 1,853 | $167K | 9.3% |
| 5 | $90.29 | 5,000 | $451K | 25.0% |
| Total | $90.13 avg | 20,031 |
| $1.8M |
| 100% |
| Filing → |
| INCY | SELL | 2020-07-07 | $3.6M | — | Filing → |
| INCY | SELL | 2020-02-07 | $2.7M | — | Filing → |
| INCY | SELL | 2019-12-03 | $1.9M | — | Filing → |